日韩亚洲欧美成人,人妻尝试又大又粗久久,最新国产免费AV片在线观看,亚洲欧美人成网站在线观看看,玖玖亚洲片区免费看,无码国模产在线观看免费,午夜福利一区二区东京热,欧美乱妇高清无乱码性色

掃碼關(guān)注公眾號           掃碼咨詢技術(shù)支持           掃碼咨詢技術(shù)服務(wù)
  
客服熱線:400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  關(guān)于我們  聯(lián)系我們
久久午夜夜伦鲁鲁片免费,eeuss鲁片一区二区三区四川,中文字幕亚洲乱码熟女在线萌芽
Recombinant SARS-Cov-2 Spike S1 protein, Fc & Avi (HEK293) (bs-46006P)  
訂購熱線:400-901-9800
訂購郵箱:sales@bioss.com.cn
訂購QQ:  400-901-9800
技術(shù)支持:techsupport@bioss.com.cn
100ug/3980.00元
500ug/12500.00元
大包裝/詢價
產(chǎn)品編號 bs-46006P
英文名稱 Recombinant SARS-Cov-2 Spike S1 protein, Fc & Avi (HEK293)
中文名稱 重組SARS冠狀病毒2 Spike S1 蛋白
別    名 coronavirus spike Protein, 2019-nCoV; cov spike Protein, 2019-nCoV; novel coronavirus RBD Protein, 2019-nCoV; novel coronavirus s1 Protein, 2019-nCoV; novel coronavirus spike Protein, 2019-nCoV; RBD Protein, 2019-nCoV; S1 Protein, 2019-nCoV; pike RBD Prot  新冠病毒S蛋白; 新冠S蛋白; 新冠S1蛋白; SARS-CoV-2 S1蛋白;
Specific References  (1)     |     bs-46006P has been referenced in 1 publications.
[IF=4.38] Lalioti, Vasiliki. et al. Cell surface detection of vimentin, ACE2 and SARS-CoV-2 Spike proteins reveals selective colocalization at primary cilia. SCI REP-UK. 2022 Apr;12(1):1-19  Other ;  Other.  
理論分子量 102 kDa
檢測分子量 150-180
性    狀 Lyophilized or Liquid
濃    度 >0.5 mg/ml
物    種 SARS-Cov-2
序    列 14-683/1273
純    度 >95% as determined by SDS-PAGE
純化方法 AC
內(nèi)毒素 Not analyzed
表達系統(tǒng) HEK293 cell
活性 Yes
標(biāo)簽 Fc & Avi
緩 沖 液 Lyophilized from 0.22um filtered solution in 2X PBS (pH7.4). Normally 5% trehalose is added as protectant before lyophilization.
保存條件 Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles.
注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

版權(quán)所有 2004-2026 jsctr.net 北京博奧森生物技術(shù)有限公司
通過國際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫(yī)療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網(wǎng)安備110107000727號